Annual CFF
$4.05 M
-$73.72 M-94.79%
December 31, 2023
Summary
- As of February 8, 2025, TNYA annual cash flow from financing activities is $4.05 million, with the most recent change of -$73.72 million (-94.79%) on December 31, 2023.
- During the last 3 years, TNYA annual CFF has fallen by -$143.22 million (-97.25%).
- TNYA annual CFF is now -98.06% below its all-time high of $208.97 million, reached on December 31, 2021.
Performance
TNYA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$31.00 K
-$539.00 K-94.56%
September 30, 2024
Summary
- As of February 8, 2025, TNYA quarterly cash flow from financing activities is $31.00 thousand, with the most recent change of -$539.00 thousand (-94.56%) on September 30, 2024.
- Over the past year, TNYA quarterly CFF has increased by +$31.00 thousand (+100.00%).
- TNYA quarterly CFF is now -99.98% below its all-time high of $190.27 million, reached on September 30, 2021.
Performance
TNYA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$47.74 M
+$31.00 K+0.06%
September 30, 2024
Summary
- As of February 8, 2025, TNYA TTM cash flow from financing activities is $47.74 million, with the most recent change of +$31.00 thousand (+0.06%) on September 30, 2024.
- Over the past year, TNYA TTM CFF has dropped by -$33.42 million (-41.18%).
- TNYA TTM CFF is now -83.81% below its all-time high of $294.92 million, reached on September 30, 2021.
Performance
TNYA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TNYA Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -94.8% | +100.0% | -41.2% |
3 y3 years | -97.3% | +100.0% | -41.2% |
5 y5 years | -86.7% | +100.0% | -41.2% |
TNYA Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -98.1% | at low | -100.0% | +106.2% | -77.2% | >+9999.0% |
5 y | 5-year | -98.1% | at low | -100.0% | +102.4% | -83.8% | >+9999.0% |
alltime | all time | -98.1% | at low | -100.0% | +102.4% | -83.8% | >+9999.0% |
Tenaya Therapeutics Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $31.00 K(-94.6%) | $47.74 M(+0.1%) |
Jun 2024 | - | $570.00 K(-98.8%) | $47.71 M(-7.0%) |
Mar 2024 | - | $46.77 M(>+9900.0%) | $51.32 M(+1167.5%) |
Dec 2023 | $4.05 M(-94.8%) | $371.00 K(>+9900.0%) | $4.05 M(-95.0%) |
Sep 2023 | - | $0.00(-100.0%) | $81.16 M(-0.0%) |
Jun 2023 | - | $4.18 M(-934.1%) | $81.17 M(+5.1%) |
Mar 2023 | - | -$501.00 K(-100.6%) | $77.25 M(-0.7%) |
Dec 2022 | $77.77 M | $77.49 M(>+9900.0%) | $77.77 M(>+9900.0%) |
Sep 2022 | - | $6000.00(-97.7%) | $260.00 K(-99.9%) |
Jun 2022 | - | $260.00 K(+1633.3%) | $190.53 M(+0.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $15.00 K(-171.4%) | $188.97 M(-9.6%) |
Dec 2021 | $208.97 M(+41.9%) | -$21.00 K(-100.0%) | $208.97 M(-29.1%) |
Sep 2021 | - | $190.27 M(<-9900.0%) | $294.92 M(+117.9%) |
Jun 2021 | - | -$1.30 M(-106.5%) | $135.34 M(-0.9%) |
Mar 2021 | - | $20.02 M(-76.7%) | $136.61 M(-7.2%) |
Dec 2020 | $147.27 M(+382.7%) | - | - |
Dec 2020 | - | $85.92 M(+179.9%) | $147.27 M(+140.1%) |
Sep 2020 | - | $30.70 M(<-9900.0%) | $61.34 M(+100.2%) |
Jun 2020 | - | -$21.00 K(-100.1%) | $30.65 M(-0.1%) |
Mar 2020 | - | $30.67 M | $30.67 M |
Dec 2019 | $30.51 M | - | - |
FAQ
- What is Tenaya Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual CFF year-on-year change?
- What is Tenaya Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly CFF year-on-year change?
- What is Tenaya Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tenaya Therapeutics?
- What is Tenaya Therapeutics TTM CFF year-on-year change?
What is Tenaya Therapeutics annual cash flow from financing activities?
The current annual CFF of TNYA is $4.05 M
What is the all time high annual CFF for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual cash flow from financing activities is $208.97 M
What is Tenaya Therapeutics annual CFF year-on-year change?
Over the past year, TNYA annual cash flow from financing activities has changed by -$73.72 M (-94.79%)
What is Tenaya Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TNYA is $31.00 K
What is the all time high quarterly CFF for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly cash flow from financing activities is $190.27 M
What is Tenaya Therapeutics quarterly CFF year-on-year change?
Over the past year, TNYA quarterly cash flow from financing activities has changed by +$31.00 K (+100.00%)
What is Tenaya Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TNYA is $47.74 M
What is the all time high TTM CFF for Tenaya Therapeutics?
Tenaya Therapeutics all-time high TTM cash flow from financing activities is $294.92 M
What is Tenaya Therapeutics TTM CFF year-on-year change?
Over the past year, TNYA TTM cash flow from financing activities has changed by -$33.42 M (-41.18%)